InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,844.87
(
-0.62%
)
US TECH 100
20,295.60
(
-0.75%
)
Dow Jones
42,289.52
(
-0.60%
)
Brent Oil
76.05
(
2.97%
)
Bitcoin
96,503.31
(
2.25%
)
Post# of 254086
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120951
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 187166

Saturday, 02/07/2015 11:34:51 AM

Saturday, February 07, 2015 11:34:51 AM

Post# of 254086
The MRK trial in question will have all or almost all of its patients from outside the US. Now that Harvoni and V-Pak are widely available in the US, it would be nearly impossible to recruit US patients into a trial where half of them got Sovaldi + PEG/riba.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up